| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/22/2007 | WO2006138673A3 Synthetic processes for the preparation of aminocyclohexyl ether compounds |
| 03/22/2007 | WO2006134385A3 Anti-inflammatory agents |
| 03/22/2007 | US20070066850 Catalysts |
| 03/22/2007 | US20070066835 Process for the synthesis of amorphous atorvastain calcium |
| 03/22/2007 | US20070066834 Ionic liquids |
| 03/22/2007 | US20070066679 Crystalline sodium atorvastatin |
| 03/22/2007 | US20070066678 Crystalline sodium atorvastatin |
| 03/22/2007 | US20070066677 serine proteases such as dipeptidyl peptidases inhibitor; antidiabetic agent; metabolic disorders, hyperglycosemia, hyperglycosemia, gastrointestinal, viral, autoimmune, dermatological, psychosomatic, depressive, and neuropsychiatric disorders, obesity, psoriasis, intestinal distress, arthritis |
| 03/22/2007 | US20070066675 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 03/22/2007 | DE102005041570A1 Hoch verzweigte Reagenzien zur Modifaktion von Biopharmazeutika, deren Herstellung und Anwendung Highly branched reagents for Modifaktion of biopharmaceuticals, their preparation and use |
| 03/22/2007 | CA2622222A1 Therapeutic pyrrolidines |
| 03/22/2007 | CA2620243A1 4-substituted pyrr0lidin-2-0nes and their use |
| 03/21/2007 | EP1763531A1 Hepatitis c inhibitor peptide analogs |
| 03/21/2007 | EP1763511A1 Phenoxyacetic acid derivatives as ppar agonists |
| 03/21/2007 | EP1763497A1 Method for producing alkenes by the elimination of water from alcohols, using alkylphosphonic acid anhydrides |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | CN1934153A Novel solvent for producing polyurethane dispersions |
| 03/21/2007 | CN1934081A Novel benayl(idene)-lactam derivatives |
| 03/21/2007 | CN1934080A Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
| 03/21/2007 | CN1934079A Anthraquinone compounds as anti cancer compounds |
| 03/21/2007 | CN1931839A Synthesis process of N-substituted pyrrole |
| 03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CA2547216A1 Process for annealing amorphous atorvastatin |
| 03/20/2007 | US7193091 Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
| 03/20/2007 | US7193090 Preparation of atorvastatin |
| 03/20/2007 | US7193067 Derived from 2-aryl-3-alkoxycarbonyl-5-pyrrolinones and 2-aryl-5-pyrrolinones by reaction with diamines or diazo compounds |
| 03/20/2007 | US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192978 Pyrrolidinium derivatives |
| 03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
| 03/20/2007 | US7192969 Ester derivatives |
| 03/20/2007 | US7192965 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production |
| 03/20/2007 | CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/15/2007 | WO2007029364A1 2’-deoxyguanosine hybrid compound containing pyrrole amide tetramer, method of producing the same and production intermediate therefor |
| 03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | US20070060624 Novel bioisosteres of actinonin |
| 03/15/2007 | US20070060596 Selective modulators of prostaglandin E2 at EP1 receptors; analgesics, antiinflammatory agents; neurodegenerative diseases, bone or renal disorders; 1-({5-bromo-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-carboxylic acid |
| 03/15/2007 | US20070060587 Indane derivates as muscarinic receptor agonists |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060570 Sulfopyrroles |
| 03/15/2007 | US20070060523 Preparation of poly(4-aminopyrrole-2-carboxamide) having the terminal amide group substituted with a 2-amidinoethyl- group; amidating the carbonyl chloride with 2-aminopropionitrile and subjecting the product to the Pinner reaction |
| 03/15/2007 | US20070060497 Reagents for modifying biopharmaceuticals, the use and production thereof |
| 03/15/2007 | US20070060480 Heteroaroyl-substituted phenylalanineamides |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621104A1 2'-deoxyguanosine hybrid compound containing pyrrole amide tetramer, method of producing the same and production intermediate therefor |
| 03/14/2007 | EP1761489A1 Crystalline form of atorvastatin hemi calcium |
| 03/14/2007 | EP1761488A1 Lactam tachykinin receptor antagonists |
| 03/14/2007 | EP1515949B1 Mitotic kinesin inhibitors |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP0627420B1 Process for the synthesis of maleimide compound improved in storage stability |
| 03/14/2007 | CN1929840A 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation |
| 03/14/2007 | CN1927839A Compound of 1,4-di(arylamido substituted alkylamino)-5,8-dihydroxyanthraquinone and preparation method thereof |
| 03/14/2007 | CN1927832A 1-(4-methoxyphenyl)-2-trifluoromethyl-tetrahydropyrrole and synthesis method thereof |
| 03/14/2007 | CN1304409C Process for producing indolopyrrolocarbazole derivative |
| 03/13/2007 | US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189754 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | CA2356029C Material for photo-alignment layer, photo-alignment layer and method of manufacturing the same |
| 03/13/2007 | CA2286610C Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium |
| 03/08/2007 | WO2007026916A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 03/08/2007 | WO2007026654A1 Enamide and process for producing the same, and dienamide and process for producing the same |
| 03/08/2007 | WO2007026312A1 1,3-diaminobenzene derivatives and colorants comprising these compounds |
| 03/08/2007 | WO2007026224A2 5-ht1b antagonist composition for depression, anxiety and cognition |
| 03/08/2007 | WO2007025763A2 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof |
| 03/08/2007 | WO2007003782A3 Novel functionalised transfer agents for controlled radical polymerisation raft, raft methods using said transfer agents and polymers obtainable thereby |
| 03/08/2007 | US20070055064 Process for the crystallisation of guandinium salts |
| 03/08/2007 | US20070054954 Method of manufacturing glimepiride and the respective intermediate |
| 03/08/2007 | US20070054945 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/08/2007 | US20070054214 Acid generators, sulfonic acids, sulfonyl halides, and radiation sensitive resin compositions |
| 03/08/2007 | CA2621182A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 03/07/2007 | EP1760081A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |
| 03/07/2007 | EP1760076A1 FAP Inhibitors |
| 03/07/2007 | EP1760075A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof |
| 03/07/2007 | EP1760072A1 1,3-diaminobenzene derivatives and colorants comprising these compounds |
| 03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
| 03/07/2007 | EP1758855A1 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation |
| 03/07/2007 | EP1758854A1 Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/07/2007 | EP1758583A2 Arylpiperazine derivatives useful as adrenergic receptor antagonists |
| 03/07/2007 | EP1758582A1 Amido compounds and their use as pharmaceuticals |
| 03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |
| 03/07/2007 | CN1926103A Sulphonylpyrroles as HDAC inhibitors |
| 03/07/2007 | CN1926102A Process for preparing N-protected 4-ketoproline derivatives |
| 03/07/2007 | CN1926094A Amide derivatives, process for production of the same, and method for application thereof as insecticide |
| 03/07/2007 | CN1925862A Treatment of diseases associated with the EGR-1 enhancer element |